Home Newsfeeds Nurix Therapeutics Q2 EPS $(1.01) Down From $(0.60) YoY

Nurix Therapeutics Q2 EPS $(1.01) Down From $(0.60) YoY

Nurix Therapeutics (NASDAQ:NRIX) reported quarterly losses of $(1.01) per share. This is a 68.33 percent decrease over losses of $(0.60) per share from the same period last year.

byBill Haddad

July 7, 2022

1 minute read

Nurix Therapeutics (NASDAQ:NRIX) reported quarterly losses of $(1.01) per share. This is a 68.33 percent decrease over losses of $(0.60) per share from the same period last year.

DoorDash Embraces AI Chatbot to Revolutionize Food Ordering and Gain Competitive Edge

By Anusuya Lahiri

July 28, 7:42 AM

DoorDash, Inc (NYSE: DASH) has leveraged an artificial intelligence-based chatbot to speed up ordering and help customers find food options.

AAPL

E.Merge Technology Acquisition Corp. Announces Liquidation For ~$10.06/Share

By Benzinga Newsdesk

August 22, 4:16 PM

E.Merge Technology Acquisition Corp. (NASDAQ:ETAC) (the "Company") announced today that, due to its inability to consummate an initial business combination within the time period required by its Second Amended

ETAC

Tesla, Amazon, Micron, Sintx, Zymeworks: Why These 5 Stocks Are Drawing Investors’ Attention Today

By Bhavik Nair

December 21, 8:47 PM

U.S. markets soared on Wednesday as consumer confidence surged to an eight-month high in December following a drop in inflation and the labor market remaining strong. Twelve-month inflation expectations fell to their lowest level since Sept. 2021, at 6.7%, according to Reuters.

AMZN